August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
May 1, 2024
Yahoo News featured comments from the University of Cincinnati's Rekha Chaudhary in a story about rising rates of diagnoses and deaths from colorectal cancers among young people.
June 12, 2024
The University of Cincinnati Cancer Center announced a street in Uptown Cincinnati has been renamed Healing Way in anticipation of the opening of the Blood Cancer Healing Center.
August 11, 2021
Researchers at the University of Cincinnati College of Medicine have developed a computerized decision analytic model to compare projected outcomes of three vaccine strategies: a patient opts for a messenger RNA vaccine, a patient decides to get an adenovirus vector vaccine or the patient simply forgoes a vaccine altogether.
June 1, 2020
Dr. Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine was interviewed by CNBC on the safest ways to vacation this summer in the midst of COVID-19.
November 13, 2020
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions. Yashu Dhamija, MD, a first-year fellow in the UC Division of Immunology, Allergy, and Rheumatology, presented his findings in an abstract while discussing a medically challenging case at the virtual American College of Allergy, Asthma and Immunology (ACAAI) scientific meeting held November 13-15.
February 22, 2022
Health experts in the United States are monitoring an increase in cases of bird flu in several states, including Indiana, Kentucky and Virginia. In January, the United States Department of Agriculture detected the first U.S. bird flu case after a hunted wild bird tested positive for the virus in Colleton County, South Carolina. Experts reported that it was the H5N1 strain, a highly pathogenic avian influenza virus (HPAI) — the same strain responsible for fatal poultry outbreaks across Europe and Asia in late 2021. In a story on the increase in bird flu published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited.
February 15, 2022
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.
February 17, 2022
New UC research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in the genes of tick saliva. The research focused on novel direct thrombin inhibitors (DTI) from tick salivary transcriptomes, or messenger RNA molecules expressed by an organism. The result is the development of new anticoagulant medications that can be used to treat patients with a variety of coronary issues, including heart attacks. The study was published in Nature Communication.
February 24, 2022
Research from UC is examining a protein that plays a key role in heart failure. The study is funded by the National Heart, Lung, and Blood Institute for just over $2 million dollars for four years and is a second renewal of a previous grant given to Sakthivel Sadayappan, PhD, professor in the Division of Cardiovascular Health and Disease in the Department of Internal Medicine at the UC College of Medicine.